Filing Details
- Accession Number:
- 0001179110-20-000653
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-17 16:14:40
- Reporting Period:
- 2020-01-15
- Accepted Time:
- 2020-01-17 16:14:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1716468 | M. Anthony Manning | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-01-15 | 21,614 | $17.96 | 27,057 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-01-15 | 7,500 | $18.85 | 34,557 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-15 | 29,114 | $28.44 | 5,443 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option(Right to Buy) | Disposition | 2020-01-15 | 4,073 | $0.00 | 4,073 | $17.96 |
Common Stock | Stock Option(Right to Buy) | Disposition | 2020-01-15 | 17,541 | $0.00 | 17,541 | $17.96 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-15 | 7,500 | $0.00 | 7,500 | $18.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-02-18 | 2024-02-18 | No | 4 | M | Direct |
0 | 2017-11-18 | 2024-02-18 | No | 4 | M | Direct |
16,500 | 2018-11-07 | 2027-02-07 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person December 14, 2018.